Long QT syndrome type 3 (LQTS3), caused by gain-of-function mutations in the SCN5A gene, encompasses a spectrum of clinical presentations, ranging from asymptomatic carriers to severe arrhythmic phenotypes, representing the “silent killer” and “brutal killer” dichotomy. This evidence concerns the gene SCN5A and long QT syndrome 3.